Patents by Inventor Susan Parks

Susan Parks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200016161
    Abstract: Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent and the anti-viral agent are administered for about five days, and the anti-viral agent is subsequently administered without the inducing agent for an additional period of about sixteen days for a total cycle of about 21 days.
    Type: Application
    Filed: July 22, 2019
    Publication date: January 16, 2020
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Susan Park Perrine, Douglas Faller
  • Publication number: 20190359655
    Abstract: Disclosed are peptides comprising a monomeric Fc fragment of an immunoglobulin recognized by a neonatal receptor (FcRn); an influenza HA protein; and a trimerization domain. Disclosed are compositions comprising one or more of the peptides described herein. Disclosed are nucleic acid sequences capable of encoding any one of the peptides described herein. Disclosed are methods for eliciting a protective immune response against influenza comprising administering to a subject an effective amount of a composition comprising a monomeric Fc fragment of an immunoglobulin recognized by a FcRn; an influenza HA protein; and a trimerization domain, wherein the administering is to a mucosal epithelium.
    Type: Application
    Filed: April 2, 2019
    Publication date: November 28, 2019
    Inventors: Xiaoping Zhu, Susan Park-Ochsner, Weizhong Li
  • Publication number: 20180368558
    Abstract: A system for providing custom cosmetic products includes a lower base configured to receive a plurality of containers, an upper base, and a plurality of dispensing cylinders coupled to the upper base. The dispensing cylinders are configured to selectively deposit cosmetic ingredients into the containers.
    Type: Application
    Filed: April 13, 2018
    Publication date: December 27, 2018
    Inventor: Susan Park
  • Patent number: 10111846
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinapathy, thalassemia and aplastic anemia.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: October 30, 2018
    Inventors: Susan Park Perrine, Douglas V. Faller
  • Patent number: 9928752
    Abstract: A social choice engine is disclosed for eliciting and receiving responses to questions or issues and ranking the responses using the Borda ranking system. The social choice engine provides a user interface to a survey administrator that allows for the defining of the social choice survey. The social choice engine also provides a pick list of possible participants, where the possible participants are members of an online community. To administer the social choice survey, the social choice engine sends electronic notifications to selected participants. The participants respond to the social choice survey through a user interface that includes interactive features. The results of the social choice survey are then displayed to the survey administrator.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: March 27, 2018
    Assignee: Overstock.com, Inc.
    Inventors: Patrick Michael Byrne, Susan Park
  • Publication number: 20170312235
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinapathy, thalassemia and aplastic anemia.
    Type: Application
    Filed: February 9, 2017
    Publication date: November 2, 2017
    Inventors: Susan Park PERRINE, Douglas V. Faller
  • Publication number: 20170143834
    Abstract: Pharmaceutical compositions, in particular, compositions comprising growth hormone (GH) and insulin-like growth factor (IGF-1) which are stable at a desirable pH without aggregation formation, and processes for preparing such compositions.
    Type: Application
    Filed: September 30, 2016
    Publication date: May 25, 2017
    Inventors: Enona GOPINATH, Susan PARK, Tsutomu ARAKAWA, Joël RICHARD, Fabio FAIS
  • Patent number: 9603818
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinapathy, thalassemia and aplastic anemia.
    Type: Grant
    Filed: September 29, 2015
    Date of Patent: March 28, 2017
    Inventors: Susan Park Perrine, Douglas V. Faller
  • Publication number: 20170027944
    Abstract: Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent and the anti-viral agent are administered for about five days, and the anti-viral agent is subsequently administered without the inducing agent for an additional period of about sixteen days for a total cycle of about 21 days.
    Type: Application
    Filed: February 18, 2015
    Publication date: February 2, 2017
    Inventors: Susan Park PERRINE, Douglas FALLER
  • Publication number: 20160151315
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinapathy, thalassemia and aplastic anemia.
    Type: Application
    Filed: September 29, 2015
    Publication date: June 2, 2016
    Inventors: Susan Park PERRINE, Douglas V. Faller
  • Publication number: 20150328282
    Abstract: Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent and the anti-viral agent are administered for about five days, and the anti-viral agent is subsequently administered without the inducing agent for an additional period of about sixteen days for a total cycle of about 21 days.
    Type: Application
    Filed: August 5, 2015
    Publication date: November 19, 2015
    Inventors: Susan Park PERRINE, Douglas FALLER
  • Patent number: 9173860
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinaphthy, thalassemia and aplastic anemia.
    Type: Grant
    Filed: November 4, 2010
    Date of Patent: November 3, 2015
    Inventors: Susan Park Perrine, Douglas V. Faller
  • Publication number: 20150235563
    Abstract: A social choice engine is disclosed for eliciting and receiving responses to questions or issues and ranking the responses using the Borda ranking system. The social choice engine provides a user interface to a survey administrator that allows for the defining of the social choice survey. The social choice engine also provides a pick list of possible participants, where the possible participants are members of an online community. To administer the social choice survey, the social choice engine sends electronic notifications to selected participants. The participants respond to the social choice survey through a user interface that includes interactive features. The results of the social choice survey are then displayed to the survey administrator.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Patrick Michael Byrne, Susan Park
  • Publication number: 20150157636
    Abstract: Disclosed are methods of treating viral disorders via the administration of an inducing agent and an anti-viral agent. In one embodiment, the inducing agent and the anti-viral agent are administered for about five days, and the anti-viral agent is subsequently administered without the inducing agent for an additional period of about sixteen days for a total cycle of about 21 days.
    Type: Application
    Filed: February 18, 2015
    Publication date: June 11, 2015
    Inventors: Susan Park PERRINE, Douglas FALLER
  • Patent number: 9047642
    Abstract: A social choice engine is disclosed for eliciting and receiving responses to questions or issues and ranking the responses using the Borda ranking system. The social choice engine provides a user interface to a survey administrator that allows for the defining of the social choice survey. The social choice engine also provides a pick list of possible participants, where the possible participants are members of an online community. To administer the social choice survey, the social choice engine sends electronic notifications to selected participants. The participants respond to the social choice survey through a user interface that includes interactive features. The results of the social choice survey are then displayed to the survey administrator.
    Type: Grant
    Filed: November 15, 2011
    Date of Patent: June 2, 2015
    Assignee: Overstock.com, Inc.
    Inventors: Patrick Michael Byrne, Susan Park
  • Publication number: 20120283329
    Abstract: The present intervention generally relates to compositions comprising S-isomer of alpha-methyl-hydrocinnamic acid for the treatment and/or prevention of blood disorders and blood deficiencies, as well as methods for treating blood disorders and/or blood deficiency in a subject by administering a composition comprising S-isomer of alpha-methyl-hydrocinnamic acid to the subject to ameliorate at least one symptom associated with the blood disorder. Another aspect relates to administration of an S-isomer of alpha-methyl-hydrocinnamic acid stimulate multi-lineage hematopoietic cell production in a subject, for example, increasing the numbers of circulating neutrophils, erythrocytes and platelets. Accordingly, one aspect of the present invention relates to administration of S-isomer of alpha-methyl-hydrocinnamic acid, e.g., by oral administration to a subject for the treatment of blood disorders, for example but not limited to, hemaglobinaphthy, thalassemia and aplastic anemia.
    Type: Application
    Filed: November 4, 2010
    Publication date: November 8, 2012
    Inventors: Susan Park Perrine, Douglas V. Faller
  • Publication number: 20120270782
    Abstract: The present invention relates to pharmaceutical compositions. More particularly, the invention relates to formulations of growth hormone (GH) and insulin-like growth factor (IGF-1) combination compositions which provide stable pharmaceutical compositions without aggregation formation at a desirable pH, and to processes of preparation thereof.
    Type: Application
    Filed: November 17, 2010
    Publication date: October 25, 2012
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Enona Gopinath, Susan Park, Tsutomu Arakawa, Joël Richard, Fabio Fais
  • Publication number: 20120246579
    Abstract: A social choice engine is disclosed for eliciting and receiving responses to questions or issues and ranking the responses using the Borda ranking system. The social choice engine provides a user interface to a survey administrator that allows for the defining of the social choice survey. The social choice engine also provides a pick list of possible participants, where the possible participants are members of an online community. To administer the social choice survey, the social choice engine sends electronic notifications to selected participants. The participants respond to the social choice survey through a user interface that includes interactive features. The results of the social choice survey are then displayed to the survey administrator.
    Type: Application
    Filed: November 15, 2011
    Publication date: September 27, 2012
    Applicant: OVERSTOCK.COM, INC.
    Inventors: Patrick Michael Byrne, Susan Park
  • Publication number: 20060217231
    Abstract: An interactive exercise device for measuring and displaying exercise performance parameters, the interactive exercise device including a step measuring device that outputs a step signal corresponding to each step walked by a user, a processor for determining a plurality of exercise performance parameters based on the step signals output from the step measuring device, a memory for storing the determined exercise performance parameters, a menu-driven interface display for displaying a plurality of menus, the menus for displaying at least the determined exercise performance parameters, a user input device for operation by the user to select a display of one of the menus on the interface display and to provide input data corresponding to a selected display, and an interface connection for connecting the interactive exercise device to an external computing device, the interface connection supporting an upload of the determined exercise performance parameters from the interactive exercise device to the external co
    Type: Application
    Filed: March 24, 2005
    Publication date: September 28, 2006
    Applicant: WalkStyles, Inc.
    Inventors: Susan Parks, Dennis Parks, Richard Sagey, Chuck Kalina
  • Publication number: 20030131434
    Abstract: A food preparation utensil has a body, a flexible wiper and a handle. The body has a food-contacting surface bounded by a peripheral edge. The flexible wiper extends outwardly from at least a portion of the peripheral edge. The handle is coupled to the body and extends from the body in a direction that is opposite the food-contacting surface. The body can be inserted into an opening of a container and into contact with a food product in the container.
    Type: Application
    Filed: January 13, 2003
    Publication date: July 17, 2003
    Inventor: Lonnette Susan Parks